share_log

步长制药(603858.SH):拟放弃优先受让控股子公司股权

Shandong Buchang Pharmaceuticals (603858.SH): Plans to give up the preferential acquisition of equity in its controlling subsidiaries.

Gelonghui Finance ·  Dec 26, 2024 06:09

Gelonghui, December 26 - Shandong Buchang Pharmaceuticals (603858.SH) announced that its controlling subsidiary Shanghai Hupu's shareholder Wang Baocai intends to transfer his unpaid 0.05% equity in Shanghai Hupu to Zhao Xiaogang at a transaction price of 0 yuan, and intends to transfer his unpaid 0.025% equity in Shanghai Hupu to Cheng Kai at a transaction price of 0 yuan. The company agrees to waive its preemptive rights, and after the transaction is completed, the company will maintain its 71.30% equity stake in Shanghai Hupu.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment